Patents by Inventor Montserrat Cano

Montserrat Cano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-CYANOPYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS
    Publication number: 20110152333
    Abstract: The invention provides new oxazolidinone compounds of formula (I) wherein R1, R2 and R3 have different meanings. Preparative processes, pharmaceutical compositions, and uses thereof in the treatment of bacterial infections are also provided.
    Type: Application
    Filed: June 29, 2009
    Publication date: June 23, 2011
    Applicant: FERRER INTERNACIONAL, S.A.
    Inventors: Montserrat Cano, Albert Palomer, Antonio Guglietta
  • 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS
    Publication number: 20110136829
    Abstract: The invention provides new oxazolidinone compounds of formula (I) wherein R, R1, R2 and R3 have different meanings. Preparative processes, pharmaceutical compositions, and uses thereof in the treatment of bacterial infections are also provided.
    Type: Application
    Filed: June 29, 2009
    Publication date: June 9, 2011
    Applicant: FERRER INTERNACIONAL, S.A.
    Inventors: Montserrat Cano, Albert Palomer, Antonio Guglietta
  • Oxazolidinone compounds, and compositions and methods related thereto
    Patent number: 7759351
    Abstract: The invention provides new oxazolidinone compounds of formula (I) wherein A is certain heterocycles optionally substituted; R1, R2, R3 and R4 are independently selected from —H and halogen; X is selected from O, S, NR9 and CR9R10; R9 and R10 having different meanings; Y is selected from O, S, SO, SO2, NO, NR12 and CR12R13; R12 and R13 having different meanings. It also provides different processes for the preparation of such compounds. Oxazolidinone compounds of formula (I) are active against Gram-positive and some Gram-negative human and veterinary pathogens with a weak monoamine oxidase (MAO) inhibitory activity. They are useful for the treatment of bacterial infections.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: July 20, 2010
    Assignee: Ferrer Internacional, S.A.
    Inventors: Montserrat Cano, Albert Palomer, Antonio Guglietta
  • OXAZOLIDINONE COMPOUNDS, AND COMPOSITIONS AND METHODS RELATED THERETO
    Publication number: 20090062266
    Abstract: The invention provides new oxazolidinone compounds of formula (I) wherein A is certain heterocycles optionally substituted; R1, R2, R3 and R4 are independently selected from —H and halogen; X is selected from O, S, NR9 and CR9R10; R9 and R10 having different meanings; Y is selected from O, S, SO, SO2, NO, NR12 and CR12R13; R12 and R13 having different meanings. It also provides different processes for the preparation of such compounds. Oxazolidinone compounds of formula (I) are active against Gram-positive and some Gram-negative human and veterinary pathogens with a weak monoamine oxidase (MAO) inhibitory activity. They are useful for the treatment of bacterial infections.
    Type: Application
    Filed: June 26, 2006
    Publication date: March 5, 2009
    Applicant: Ferrer Internacional, S.A.
    Inventors: Montserrat Cano, Albert Palomer, Antonio Guglietta
  • Oxazolidinone Compounds and Compositions and Methods Related Thereto
    Publication number: 20090005369
    Abstract: The invention provides new oxazolidinones of formula (I), where R1, R2, R3 and R4 are independently selected from H, F and Cl; A is certain heterocycles optionally substituted; X is selected from O, S, NR8 and CR8R9; R8 and R9 having different meanings; Y is selected from O, S, SO, SO2, NO, NR11 and CR11R12; R11 and R12 having different meanings; and n is selected from 0 and 1. It also provides different processes for the preparation of such compounds. Oxazolidinones compounds of formula (I) are active against Gram-positive and some Gram-negative human and veterinary pathogens with a weak monoamine oxidase (MAO) inhibitory activity. They are useful for the treatment of bacterial infections.
    Type: Application
    Filed: July 26, 2005
    Publication date: January 1, 2009
    Inventors: Montserrat Cano, Albert Palomer, Antonio Guglietta